Barclays maintains Overweight on Jabil, raises price target to $426

0 min read | Published on 18 Jun 2026, 10:00 PM |Updated on 18 Jun 2026, 10:00 PM

Reviewed by

Radhika SScanX News Team

Key Highlights

Barclays analyst Tim Long maintains an Overweight rating on Jabil and raises the price target from $304 to $426, indicating a positive outlook.

*this image is generated using AI for illustrative purposes only.

Barclays analyst Tim Long has maintained an Overweight rating on Jabil (NYSE: JBL) and raised the price target to $426 from $304. The adjustment signals a stronger outlook for the company's stock performance.

The revised price target represents a significant increase from the previous level. Jabil continues to be viewed favorably by the financial institution.

Metric	Value
Rating	Overweight
Previous Price Target	$304
New Price Target	$426

What specific factors drove the 40% increase in Jabil's price target?

How might this rating upgrade influence investor sentiment toward Jabil in the short term?

What are the potential risks that could prevent Jabil from reaching the new $426 target?

UBS maintains Neutral on Jabil, raises price target to $430

0 min read | Published on 18 Jun 2026, 09:35 PM |Updated on 18 Jun 2026, 09:35 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

UBS analyst David Vogt maintains a Neutral rating on Jabil and raises the price target to $430 from $380, signaling a revised valuation outlook for the NYSE-listed company.

*this image is generated using AI for illustrative purposes only.

UBS analyst David Vogt has maintained a Neutral rating on Jabil while raising the price target to $430 from the previous $380. The revised target indicates an updated valuation perspective on the stock, which trades on the NYSE under the ticker symbol JBL.

Rating and Target Details

The research note from UBS outlines the following key changes regarding Jabil's stock:

Metric	New Value	Previous Value
Rating	Neutral	Neutral
Price Target	$430	$380

The Neutral stance suggests that the stock is expected to perform in line with the broader market or sector averages over the near term, despite the higher price objective.

What specific factors drove UBS to raise the price target while maintaining a Neutral rating?

How might Jabil's upcoming earnings report influence the stock's performance relative to the new target?

What are the potential risks or opportunities that could shift Jabil's rating from Neutral in the future?